Skip to main content
Watch Insiders
AKTSTechnology

Akoustis Technologies Inc (AKTS) Insider Trading

In the last 90 days, 1 Akoustis Technologies Inc (AKTS) insider reported no open-market purchases and 1 sale totaling $258,621. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 23, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 23, 2026Akos CzibereChief Medical OfficerSale12,500$20.69$258,621
Jul 20, 2026Ken HerrmannDirectorSale4,856$24.56$119,274
Jul 17, 2026Ken HerrmannDirectorSale3,065$25.21$77,259
Jul 8, 2026Shulamit Ron-BiggerChief Operating OfficerSale50,000$27.75$1,387,560
Jul 8, 2026Akos CzibereChief Medical OfficerSale50,000$27.77$1,388,700

Common questions

AKTS insider trading FAQ

Are AKTS insiders buying or selling?
Over the last 90 days, AKTS insiders were net sellers, reporting $0.00 of open-market purchases and $258,621 of sales.
When was the last AKTS insider purchase?
No open-market insider purchase of Akoustis Technologies Inc stock was reported in the last 90 days.
Where does AKTS insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Akoustis Technologies Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.